| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:2187.)
© 2003 American Heart Association, Inc.
Original Contributions |
From the Department of Internal Medicine, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Correspondence to Claudia R.L. Cardoso, Rua Cróton 72, Jacarepagua, CEP 22750240, Rio de Janeiro, Brasil. E-mail claudiacardoso{at}hucff.ufrj.br
Background and Purpose QTc interval prolongation is a predictor of cardiovascular morbidity and mortality in general populations and in patients with diabetes. The aim of this study was to investigate the predictors of stroke in patients with type 2 diabetes, with particular emphasis on the independent role of QT interval parameters.
Methods We carried out a long-term follow-up study with 471 type 2 diabetics. Several clinical, laboratory, ECG, and echocardiographic variables were recorded at baseline. Predictive factors for stroke were evaluated by Kaplan-Meier estimation of survival curves and by univariate and multivariate Cox survival analyses.
Results After a median follow-up of 57 months (range, 2 to 84 months), 40 incident strokes were observed. QTc interval prolongation (
470 ms1/2) was an independent predictor of stroke, with adjusted hazard ratios ranging from 2.2 to 2.9 (95% confidence intervals, 1.1 to 6.0). Other independent factors associated with stroke were older age; the presence of cerebrovascular disease at baseline; increased 24-hour proteinuria, serum triglycerides, and left ventricular mass; and decreased high-density lipoprotein cholesterol. Excluding patients with previous cerebrovascular disease from the analysis did not change the results significantly.
Conclusions QTc interval prolongation is a predictor of future stroke in patients with type 2 diabetes. Intervention studies are needed to assess whether this factor could be modified.
Key Words: diabetes mellitus electrocardiography risk factors stroke
This article has been cited by other articles:
![]() |
S. S. Chugh, K. Reinier, T. Singh, A. Uy-Evanado, C. Socoteanu, D. Peters, R. Mariani, K. Gunson, and J. Jui Determinants of Prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery Disease: The Oregon Sudden Unexpected Death Study Circulation, February 10, 2009; 119(5): 663 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Pappachan, J Sebastian, B C Bino, K Jayaprakash, K Vijayakumar, P Sujathan, and L A Adinegara Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis Postgrad. Med. J., April 1, 2008; 84(990): 205 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xiao, X. Luo, H. Lin, Y. Zhang, Y. Lu, N. Wang, Y. Zhang, B. Yang, and Z. Wang MicroRNA miR-133 Represses HERG K+ Channel Expression Contributing to QT Prolongation in Diabetic Hearts J. Biol. Chem., April 27, 2007; 282(17): 12363 - 12367. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Salles, K. V. Bloch, and C. R.L. Cardoso Mortality and Predictors of Mortality in a Cohort of Brazilian Type 2 Diabetic Patients Diabetes Care, June 1, 2004; 27(6): 1299 - 1305. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |